361 Capital’s Pediatrix Medical MD Stock Holding History

361 Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-25,359	Closed	-$1.41M	–	360
2018 Q1	$1.41M	Buy	+25,359	New	+$1.39M	0.35%	162

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

361 Capital's MD Position: Q2 2018 in Review

361 Capital sold out of Pediatrix Medical (MD) in Q2 2018, closing a stake of 25,359 shares — an estimated $1.41M sold.

361 Capital first reported a position in MD in Q1 2018 and held it in 1 quarter. The position peaked at $1.41M in Q1 2018. 322 funds tracked by Wall St. Rank hold MD as of Q2 2018.

361 Capital reported no remaining Pediatrix Medical position as of Q2 2018 after selling out during the quarter.
361 Capital sold 25,359 Pediatrix Medical shares in Q2 2018, an estimated $1.41M.
361 Capital first reported a position in Pediatrix Medical in Q1 2018 and held it in 1 quarter.
361 Capital's Pediatrix Medical position peaked at $1.41M in Q1 2018.
322 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2018.

Based on 361 Capital's 13F filing for Q2 2018, filed 14 Aug 2018.